NVEC News and Press, NVE Corporation

2024-07-17 18:48:04 ET NVE Corporation (NVEC) Q1 2025 Earnings Conference Call July 17, 2024, 5:00 PM ET Company Participants Daniel Baker - President and Chief Executive Officer Daniel Nelson - Controller and Principal Financial Officer Conference Call Partici...

2024-07-17 16:46:14 ET More on NVE NVE Corporation: Not Enough To Get Excited About NVE Corporation (NVEC) Q4 2024 Earnings Call Transcript Dividend scorecard for NVE Financial information for NVE Read the full article on Seeking Alpha For fur...

2024-06-12 05:01:32 ET Summary The charts show lots of action in the past 12 months with big moves in both directions, but not lately with NVEC staying flat. NVEC is different in how it seems to prioritize capital returns through dividends instead of growth, which is uncommon in t...

2024-05-23 00:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-05-13 09:33:14 ET Summary Everspin Technologies is a leading semiconductor firm specializing in "electron spin" memory storage, offering advantages such as energy efficiency and data retention. The company experienced a dip in MRAM sales during early 2024, but has secured a m...

2024-05-01 22:35:24 ET NVE Corporation (NVEC) Q4 2024 Earnings Conference Call May 01, 2024 05:00 PM ET Company Participants Daniel Baker - President and Chief Executive Officer Daniel Nelson - Accounting Manager and Principal Financial Officer Conference Call ...

2024-05-01 18:02:05 ET More on NVE Dividend scorecard for NVE Financial information for NVE Read the full article on Seeking Alpha For further details see: NVE GAAP EPS of $0.79, revenue of $7.08M

Enact Holdings Inc. (ACT) is expected to report $0.99 for Q1 2024 FormFactor Inc. (FORM) is expected to report $0.09 for Q1 2024 SAAB AB - Class B (SAABF) is expected to report for quarter end 2024-03-31 Lumos Pharma Inc. (LUMO) is expected to report $-1.21 for Q1 2024 Axis Capita...

2024-03-24 15:10:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-03-14 13:12:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...